As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period

Summary

This study will evaluate the efficacy of as-needed Budesonide/formoterol Turbuhaler 160/4.5 µg/d in the period of step down in well controlled asthmatic patient comparing with standard maintenance therapy in step-2 management in asthma guildeline which is low dose inhaled corticosteroid.

Timeline

Start

2020-04-01

Primary completion

2021-10-10

Completion

2022-05-30

Drugs

Indications